title: Restraint, hunger, and disinhibition following treatment for binge-eating disorder.
abstract: OBJECTIVE
  To examine changes in total, flexible and rigid restraint, hunger, and disinhibition in obese individuals with Binge-Eating Disorder (BED), and assess whether these variables are associated with binge abstinence at post-treatment and during two-year follow-up.
  
  
  METHODS
  A total of 116 obese individuals with BED were randomized to a 20-week treatment trial plus two-year follow-up. Using the Eating Inventory (EI), we assessed these factors at pretreatment, post-treatment, and follow-up time-points and examined their relationship to binge abstinence at post-treatment, 12- and 24-month follow-up.
  
  
  RESULTS
  Low disinhibition and high-total restraint are associated with post-treatment binge abstinence. There are no significant relationships between post-treatment EI variables and binge abstinence at 12- and 24-month follow-up.
  
  
  CONCLUSIONS
  Reducing disinhibition as well as increasing EI dietary restraint during BED treatment may be important for short-term success.
authors.affiliation: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, USA.
authors.forename: Kristina A
authors.initials: KA
authors.lastname: Downe
authors.forename: Juli A
authors.initials: JA
authors.lastname: Goldfein
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Devlin
mesh_terms: D000328:Adult; D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D015992:Body Mass Index; D052018:Bulimia Nervosa / Q000175:diagnosis / Q000523:psychology* / Q000628:therapy*; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D004038:Diet, Reducing / Q000523:psychology*; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D006815:Hunger; D007266:Inhibition, Psychological; D007389:Internal-External Control; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000175:diagnosis / Q000523:psychology* / Q000628:therapy*; D010555:Personality Inventory / Q000706:statistics & numerical data; D011594:Psychometrics; D055815:Young Adult
chemical_list: D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine